Bain Capital Double Impact - Private Equity Firm Profile | CT Acquisitions Directory - CT Acquisitions

Firm at a glance

Bain Capital Double Impact is a platform private equity firm founded in 2015 with offices in Boston and New York, per its own website [S1][S2]. The firm reported approximately $2.6 billion in assets under management as of December 31, 2025 [S1].

What they buy

Based on its public portfolio, Bain Capital Double Impact acquires businesses across three primary sectors: health and wellness, education and workforce development, and climate and sustainability [S3]. The firm’s portfolio includes healthcare service providers, educational technology and service companies, and environmentally focused businesses. Observed transactions span both large-scale platforms such as athenahealth and smaller growth-stage companies across its focus areas [S3].

Portfolio

Health & Wellness

athenahealth (2021), Basic Home Infusion (2022), ConvenientMD (2021), Excelsia (2020), Legacy Hospice (2025), and Rodeo Dental (2019) [S3].

Education & Workforce Development

Branching Minds (2024) and Meteor Education (2023) [S3].

Climate & Sustainability

AqueoUS Vets (2021) and BW Fusion (2024) [S3].

Other Portfolio Companies

Arosa (2018), Beatnic (2018), Broadstep (2019), Cotopaxi (2021), FreeWill (2022), Lillio (2021), Pacha Soap Co (2021), and Sustainable Restaurant Group (2018) [S3].

Recent activity (last 24 months)

* American College of Education acquisition, January 8, 2026 [S4]
* Legacy Hospice acquisition, 2025 [S3]
* TeachTown exit, June 4, 2024 [S4]
* Branching Minds acquisition, 2024 [S3]
* BW Fusion acquisition, 2024 [S3]

How this firm fits a seller

Bain Capital Double Impact appears suited for owner-operators in healthcare services, education, or sustainability-focused businesses seeking a buyer with sector concentration and capital scale. The firm’s recent activity demonstrates continued acquisition appetite through early 2026, with multiple transactions completed in education and healthcare verticals [S3][S4]. For sellers in healthcare services or educational services, the firm’s existing portfolio suggests experience building platforms in these categories. The firm completed at least one exit in the education sector during the past 24 months, indicating active portfolio management [S4].

Sources

[S1] https://www.baincapitaldoubleimpact.com/about (as of 2026-04-01 and 2025-12-31)
[S2] https://www.baincapitaldoubleimpact.com/people (as of 2026-04-01)
[S3] https://www.baincapitaldoubleimpact.com/portfolio (as of 2026-04-01)
[S4] https://www.baincapitaldoubleimpact.com/news (as of 2026-04-01)

Frequently asked questions

Does Bain Capital Double Impact buy health and wellness businesses?

Yes, per public sources, health and wellness represents a significant portion of the firm’s portfolio [S3]. The firm has acquired at least six healthcare service companies between 2019 and 2025, including hospice, infusion therapy, urgent care, and dental platforms [S3].

What companies has Bain Capital Double Impact acquired recently?

Recent acquisitions include American College of Education in January 2026, Legacy Hospice in 2025, and both Branching Minds and BW Fusion in 2024 [S3][S4]. These transactions span the firm’s education and healthcare focus areas.

Where is Bain Capital Double Impact based and how big is the firm?

The firm maintains offices in Boston and New York [S2]. As of December 31, 2025, Bain Capital Double Impact reported approximately $2.6 billion in assets under management [S1].

Is Bain Capital Double Impact still actively acquiring?

Yes, the firm completed an acquisition as recently as January 2026 with its purchase of American College of Education [S4]. The firm has completed at least four acquisitions since 2024, indicating ongoing deal activity [S3][S4].

This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.